ID   OXDA_RAT                Reviewed;         346 AA.
AC   O35078;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   02-OCT-2024, entry version 150.
DE   RecName: Full=D-amino-acid oxidase;
DE            Short=DAAO;
DE            Short=DAMOX;
DE            Short=DAO;
DE            EC=1.4.3.3 {ECO:0000269|PubMed:21981077, ECO:0000305|PubMed:21700703};
GN   Name=Dao; Synonyms=Dao1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=9473656; DOI=10.1016/s0167-4781(97)00185-1;
RA   Konno R.;
RT   "Rat D-amino-acid oxidase cDNA: rat D-amino-acid oxidase as an intermediate
RT   form between mouse and other mammalian D-amino-acid oxidases.";
RL   Biochim. Biophys. Acta 1395:165-170(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=2896644;
RA   Angermueller S., Fahimi H.D.;
RT   "Heterogenous staining of D-amino acid oxidase in peroxisomes of rat liver
RT   and kidney. A light and electron microscopic study.";
RL   Histochemistry 88:277-285(1988).
RN   [4]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND INDUCTION.
RX   PubMed=7903300; DOI=10.1016/s0021-9258(19)74201-x;
RA   D'Aniello A., D'Onofrio G., Pischetola M., D'Aniello G., Vetere A.,
RA   Petrucelli L., Fisher G.H.;
RT   "Biological role of D-amino acid oxidase and D-aspartate oxidase. Effects
RT   of D-amino acids.";
RL   J. Biol. Chem. 268:26941-26949(1993).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=17880399; DOI=10.1111/j.1460-9568.2007.05769.x;
RA   Verrall L., Walker M., Rawlings N., Benzel I., Kew J.N., Harrison P.J.,
RA   Burnet P.W.;
RT   "d-Amino acid oxidase and serine racemase in human brain: normal
RT   distribution and altered expression in schizophrenia.";
RL   Eur. J. Neurosci. 26:1657-1669(2007).
RN   [6]
RP   ACTIVITY REGULATION.
RX   PubMed=19438227; DOI=10.1021/jm900128w;
RA   Duplantier A.J., Becker S.L., Bohanon M.J., Borzilleri K.A., Chrunyk B.A.,
RA   Downs J.T., Hu L.Y., El-Kattan A., James L.C., Liu S., Lu J., Maklad N.,
RA   Mansour M.N., Mente S., Piotrowski M.A., Sakya S.M., Sheehan S.,
RA   Steyn S.J., Strick C.A., Williams V.A., Zhang L.;
RT   "Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-
RT   one series of potent D-amino acid oxidase (DAAO) inhibitors.";
RL   J. Med. Chem. 52:3576-3585(2009).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=20564560; DOI=10.1002/cbdv.200900275;
RA   Xin Y.F., Li X., Hao B., Gong N., Sun W.Q., Konno R., Wang Y.X.;
RT   "Indispensable but insufficient role of renal D-amino acid oxidase in
RT   chiral inversion of NG-nitro-D-arginine.";
RL   Chem. Biodivers. 7:1413-1423(2010).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVITY REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND BIOTECHNOLOGY.
RX   PubMed=21981077; DOI=10.1111/j.1742-4658.2011.08354.x;
RA   Frattini L.F., Piubelli L., Sacchi S., Molla G., Pollegioni L.;
RT   "Is rat an appropriate animal model to study the involvement of D-serine
RT   catabolism in schizophrenia? Insights from characterization of D-amino acid
RT   oxidase.";
RL   FEBS J. 278:4362-4373(2011).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH BSN, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=21700703; DOI=10.1074/jbc.m111.262063;
RA   Popiolek M., Ross J.F., Charych E., Chanda P., Gundelfinger E.D.,
RA   Moss S.J., Brandon N.J., Pausch M.H.;
RT   "D-amino acid oxidase activity is inhibited by an interaction with bassoon
RT   protein at the presynaptic active zone.";
RL   J. Biol. Chem. 286:28867-28875(2011).
RN   [10]
RP   FUNCTION.
RX   PubMed=23631755; DOI=10.1021/jm4002583;
RA   Hopkins S.C., Heffernan M.L., Saraswat L.D., Bowen C.A., Melnick L.,
RA   Hardy L.W., Orsini M.A., Allen M.S., Koch P., Spear K.L., Foglesong R.J.,
RA   Soukri M., Chytil M., Fang Q.K., Jones S.W., Varney M.A., Panatier A.,
RA   Oliet S.H., Pollegioni L., Piubelli L., Molla G., Nardini M., Large T.H.;
RT   "Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid
RT   oxidase inhibition by small molecules.";
RL   J. Med. Chem. 56:3710-3724(2013).
RN   [11]
RP   ACTIVITY REGULATION.
RX   PubMed=25001371; DOI=10.1042/bsr20140071;
RA   Terry-Lorenzo R.T., Chun L.E., Brown S.P., Heffernan M.L., Fang Q.K.,
RA   Orsini M.A., Pollegioni L., Hardy L.W., Spear K.L., Large T.H.;
RT   "Novel human D-amino acid oxidase inhibitors stabilize an active-site lid-
RT   open conformation.";
RL   Biosci. Rep. 34:e00133-e00133(2014).
RN   [12]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=26961980; DOI=10.1007/s00204-016-1685-z;
RA   Luks L., Sacchi S., Pollegioni L., Dietrich D.R.;
RT   "Novel insights into renal D-amino acid oxidase accumulation: propiverine
RT   changes DAAO localization and peroxisomal size in vivo.";
RL   Arch. Toxicol. 91:427-437(2017).
RN   [13]
RP   ACTIVITY REGULATION.
RX   PubMed=37289348; DOI=10.1007/s11064-023-03956-2;
RA   Fradley R., Goetghebeur P., Miller D., Burley R., Almond S., Gruart I.,
RA   Masso A., Delgado Garcia J.M., Zhu B., Howley E., Neill J.C., Grayson B.,
RA   Gaskin P., Carlton M., Gray I., Serrats J., Davies C.H.;
RT   "Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor
RT   Improves Cognitive and Social Deficits in Rodent Models for
RT   Schizophrenia.";
RL   Neurochem. Res. 48:3027-3041(2023).
RN   [14]
RP   ERRATUM OF PUBMED:37289348.
RX   PubMed=37440119; DOI=10.1007/s11064-023-03987-9;
RA   Fradley R., Goetghebeur P., Miller D., Burley R., Almond S., Gruart I.,
RA   Masso A., Delgado Garcia J.M., Zhu B., Howley E., Neill J.C., Grayson B.,
RA   Gaskin P., Carlton M., Gray I., Serrats J., Davies C.H.;
RL   Neurochem. Res. 48:3472-3472(2023).
CC   -!- FUNCTION: Catalyzes the oxidative deamination of D-amino acids with
CC       broad substrate specificity (PubMed:21700703, PubMed:21981077).
CC       Required to catabolize D-amino acids synthesized endogenously, of
CC       gastrointestinal bacterial origin or obtained from the diet, and to use
CC       these as nutrients (By similarity). Regulates the level of D-amino acid
CC       neurotransmitters in the brain, such as D-serine, a co-agonist of N-
CC       methyl D-aspartate (NMDA) receptors, and may modulate synaptic
CC       transmission (PubMed:23631755). Catalyzes the first step of the
CC       racemization of D-DOPA to L-DOPA, for possible use in an alternative
CC       dopamine biosynthesis pathway (By similarity). Also catalyzes the first
CC       step of the chiral inversion of N(gamma)-nitro-D-arginine methyl ester
CC       (D-NNA) to its L-enantiomer L-NNA that acts as a nitric oxide synthase
CC       inhibitor (By similarity). The hydrogen peroxide produced in the
CC       reaction provides protection against microbial infection; it
CC       contributes to the oxidative killing activity of phagocytic leukocytes
CC       and protects against bacterial colonization of the small intestine (By
CC       similarity). Enzyme secreted into the lumen of the intestine may not be
CC       catalytically active and could instead be proteolytically cleaved into
CC       peptides with antimicrobial activity (By similarity). The hydrogen
CC       peroxide produced in the reaction may also play a role in promoting
CC       cellular senescence in response to DNA damage (By similarity). Could
CC       act as a detoxifying agent which removes D-amino acids accumulated
CC       during aging (PubMed:7903300). {ECO:0000250|UniProtKB:P14920,
CC       ECO:0000250|UniProtKB:P18894, ECO:0000269|PubMed:21700703,
CC       ECO:0000269|PubMed:21981077, ECO:0000269|PubMed:23631755,
CC       ECO:0000269|PubMed:7903300}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a D-alpha-amino acid + H2O + O2 = a 2-oxocarboxylate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:21816, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:35179,
CC         ChEBI:CHEBI:59871; EC=1.4.3.3; Evidence={ECO:0000269|PubMed:21981077,
CC         ECO:0000305|PubMed:21700703};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-alanine + H2O + O2 = H2O2 + NH4(+) + pyruvate;
CC         Xref=Rhea:RHEA:22688, ChEBI:CHEBI:15361, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:57416; Evidence={ECO:0000269|PubMed:21981077,
CC         ECO:0000305|PubMed:21700703};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22689;
CC         Evidence={ECO:0000269|PubMed:21981077, ECO:0000305|PubMed:21700703};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-cysteine + H2O + O2 = 2-oxo-3-sulfanylpropanoate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:78791, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:35236,
CC         ChEBI:CHEBI:57678; Evidence={ECO:0000250|UniProtKB:P14920};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:78792;
CC         Evidence={ECO:0000250|UniProtKB:P14920};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-dopa + H2O + O2 = 3-(3,4-dihydroxyphenyl)pyruvate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:70971, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:29055,
CC         ChEBI:CHEBI:149689; Evidence={ECO:0000250|UniProtKB:P14920};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70972;
CC         Evidence={ECO:0000250|UniProtKB:P14920};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-leucine + H2O + O2 = 4-methyl-2-oxopentanoate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:78211, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:17865, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:143079; Evidence={ECO:0000250|UniProtKB:P14920};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:78212;
CC         Evidence={ECO:0000250|UniProtKB:P14920};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-lysine + H2O + O2 = 6-amino-2-oxohexanoate + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:37583, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:32557,
CC         ChEBI:CHEBI:58183; EC=1.4.3.3;
CC         Evidence={ECO:0000250|UniProtKB:P00371};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37584;
CC         Evidence={ECO:0000250|UniProtKB:P00371};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-methionine + H2O + O2 = 4-methylsulfanyl-2-oxobutanoate +
CC         H2O2 + NH4(+); Xref=Rhea:RHEA:78207, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:16723,
CC         ChEBI:CHEBI:28938, ChEBI:CHEBI:57932;
CC         Evidence={ECO:0000250|UniProtKB:P00371};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:78208;
CC         Evidence={ECO:0000250|UniProtKB:P00371};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-phenylalanine + H2O + O2 = 3-phenylpyruvate + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:70963, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:18005, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:57981; Evidence={ECO:0000269|PubMed:21981077};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70964;
CC         Evidence={ECO:0000269|PubMed:21981077};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-proline + O2 = 1-pyrroline-2-carboxylate + H2O2;
CC         Xref=Rhea:RHEA:78259, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:39785, ChEBI:CHEBI:57726;
CC         Evidence={ECO:0000269|PubMed:21981077};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:78260;
CC         Evidence={ECO:0000269|PubMed:21981077};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-serine + H2O + O2 = 3-hydroxypyruvate + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:70951, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:17180, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:35247; Evidence={ECO:0000269|PubMed:21981077};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70952;
CC         Evidence={ECO:0000269|PubMed:21981077};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-tryptophan + H2O + O2 = H2O2 + indole-3-pyruvate + NH4(+);
CC         Xref=Rhea:RHEA:78247, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:17640, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:57719; Evidence={ECO:0000269|PubMed:21981077};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:78248;
CC         Evidence={ECO:0000269|PubMed:21981077};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-valine + H2O + O2 = 3-methyl-2-oxobutanoate + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:78203, ChEBI:CHEBI:11851, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:74338; Evidence={ECO:0000250|UniProtKB:P14920};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:78204;
CC         Evidence={ECO:0000250|UniProtKB:P14920};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:21981077};
CC   -!- ACTIVITY REGULATION: Inhibited by benzoate, anthranilate and
CC       luvadaxistat (PubMed:21981077, PubMed:37289348). Inhibited by 3-
CC       hydroxyquinolin-2(1h)-one, 4-hydroxy-6-[2-(7-hydroxy-2-oxo-4-phenyl-2h-
CC       chromen-6- Yl)ethyl]pyridazin-3(2h)-one and 3-(7-hydroxy-2-oxo-4-
CC       phenyl-2h-chromen-6-Yl)propanoic acid (PubMed:19438227,
CC       PubMed:25001371). {ECO:0000269|PubMed:19438227,
CC       ECO:0000269|PubMed:21981077, ECO:0000269|PubMed:25001371,
CC       ECO:0000269|PubMed:37289348}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=140 mM for D-alanine (at 25 degrees Celsius and at pH 8.3)
CC         {ECO:0000269|PubMed:21981077};
CC         KM=310 mM for D-serine (at 25 degrees Celsius and at pH 8.3)
CC         {ECO:0000269|PubMed:21981077};
CC         KM=86 mM for D-proline (at 25 degrees Celsius and at pH 8.3)
CC         {ECO:0000269|PubMed:21981077};
CC         KM=15 mM for D-tryptophan (at 25 degrees Celsius and at pH 8.3)
CC         {ECO:0000269|PubMed:21981077};
CC         KM=35 mM for D-phenylalanine (at 25 degrees Celsius and at pH 8.3)
CC         {ECO:0000269|PubMed:21981077};
CC         Note=kcat is 27 sec(-1) with D-alanine as substrate (at 25 degrees
CC         Celsius and at pH 8.3) (PubMed:21981077). kcat is 6.4 sec(-1) with D-
CC         serine as substrate (at 25 degrees Celsius and at pH 8.3)
CC         (PubMed:21981077). kcat is 47 sec(-1) with D-proline as substrate (at
CC         25 degrees Celsius and at pH 8.3) (PubMed:21981077). kcat is 3.7
CC         sec(-1) with D-tryptophan as substrate (at 25 degrees Celsius and at
CC         pH 8.3) (PubMed:21981077). kcat is 8.5 sec(-1) with D-phenylalanine
CC         as substrate (at 25 degrees Celsius and at pH 8.3) (PubMed:21981077).
CC         {ECO:0000269|PubMed:21981077};
CC   -!- SUBUNIT: Monomer (PubMed:21981077). Interacts with BSN (via coiled
CC       region); the interaction is direct and inhibits DAO enzyme activity
CC       (PubMed:21700703). {ECO:0000269|PubMed:21700703,
CC       ECO:0000269|PubMed:21981077}.
CC   -!- SUBCELLULAR LOCATION: Peroxisome matrix {ECO:0000269|PubMed:26961980,
CC       ECO:0000269|PubMed:2896644}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:P14920}. Presynaptic active zone
CC       {ECO:0000269|PubMed:21700703}. Secreted {ECO:0000250|UniProtKB:P18894}.
CC       Note=Transiently present in the cytosol before being delivered to the
CC       peroxisomes (By similarity). In the cerebellum, a fraction of protein
CC       localizes to the presynaptic active zone, where its activity is
CC       regulated by protein BSN (PubMed:21700703). Secreted into the lumen of
CC       the small intestine (By similarity). {ECO:0000250|UniProtKB:P14920,
CC       ECO:0000250|UniProtKB:P18894, ECO:0000269|PubMed:21700703}.
CC   -!- TISSUE SPECIFICITY: Expressed in the cerebellum, liver and proximal
CC       tubules of the renal cortex (at protein level) (PubMed:17880399,
CC       PubMed:20564560, PubMed:21700703, PubMed:26961980, PubMed:2896644).
CC       Absent from spleen (at protein level) (PubMed:21700703).
CC       {ECO:0000269|PubMed:17880399, ECO:0000269|PubMed:20564560,
CC       ECO:0000269|PubMed:21700703, ECO:0000269|PubMed:26961980,
CC       ECO:0000269|PubMed:2896644}.
CC   -!- DEVELOPMENTAL STAGE: In the liver and kidney, progressively increases
CC       during postnatal stages (at protein level).
CC       {ECO:0000269|PubMed:7903300}.
CC   -!- INDUCTION: Increased in pups born to mothers fed D-alanine during
CC       pregnancy and suckling; not induced when mothers fed D-aspartate
CC       (PubMed:7903300). Not induced further in the cerebellum following two
CC       weeks of intraperitoneal injections of the antipsychotic haloperidol
CC       (PubMed:17880399). {ECO:0000269|PubMed:17880399,
CC       ECO:0000269|PubMed:7903300}.
CC   -!- PTM: Phosphorylated in the cerebellum; probably not by PRKACA, PRKCA or
CC       PRKCE. {ECO:0000250|UniProtKB:P14920}.
CC   -!- PTM: May be S-nitrosylated, which partially inactivates the enzyme.
CC       {ECO:0000250|UniProtKB:P14920}.
CC   -!- BIOTECHNOLOGY: In comparison to human DAO, has relatively poor activity
CC       on D-serine and other substrates, raising doubts regarding the use of
CC       rat as a model system for testing drugs against schizophrenia or
CC       amyotrophic lateral sclerosis. {ECO:0000269|PubMed:21981077}.
CC   -!- SIMILARITY: Belongs to the DAMOX/DASOX family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB003400; BAA22840.1; -; mRNA.
DR   EMBL; BC088395; AAH88395.1; -; mRNA.
DR   RefSeq; NP_446078.1; NM_053626.1.
DR   AlphaFoldDB; O35078; -.
DR   SMR; O35078; -.
DR   BioGRID; 250263; 173.
DR   IntAct; O35078; 1.
DR   MINT; O35078; -.
DR   STRING; 10116.ENSRNOP00000069135; -.
DR   BindingDB; O35078; -.
DR   ChEMBL; CHEMBL5756; -.
DR   iPTMnet; O35078; -.
DR   PhosphoSitePlus; O35078; -.
DR   PaxDb; 10116-ENSRNOP00000000881; -.
DR   Ensembl; ENSRNOT00000094356.1; ENSRNOP00000079300.1; ENSRNOG00000054962.2.
DR   GeneID; 114027; -.
DR   KEGG; rno:114027; -.
DR   UCSC; RGD:621138; rat.
DR   AGR; RGD:621138; -.
DR   CTD; 1610; -.
DR   RGD; 621138; Dao.
DR   eggNOG; KOG3923; Eukaryota.
DR   GeneTree; ENSGT00390000018635; -.
DR   InParanoid; O35078; -.
DR   OMA; LWWPYRI; -.
DR   OrthoDB; 5359at2759; -.
DR   PhylomeDB; O35078; -.
DR   TreeFam; TF313887; -.
DR   BRENDA; 1.4.3.3; 5301.
DR   Reactome; R-RNO-389661; Glyoxylate metabolism and glycine degradation.
DR   Reactome; R-RNO-9033241; Peroxisomal protein import.
DR   SABIO-RK; O35078; -.
DR   PRO; PR:O35078; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISO:RGD.
DR   GO; GO:0005782; C:peroxisomal matrix; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; ISS:UniProtKB.
DR   GO; GO:0048786; C:presynaptic active zone; IDA:UniProtKB.
DR   GO; GO:0008718; F:D-amino-acid dehydrogenase activity; ISO:RGD.
DR   GO; GO:0003884; F:D-amino-acid oxidase activity; ISO:RGD.
DR   GO; GO:0071949; F:FAD binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0055130; P:D-alanine catabolic process; ISO:RGD.
DR   GO; GO:0019478; P:D-amino acid catabolic process; ISO:RGD.
DR   GO; GO:0036088; P:D-serine catabolic process; ISO:RGD.
DR   GO; GO:0070178; P:D-serine metabolic process; ISO:RGD.
DR   GO; GO:0007586; P:digestion; ISS:UniProtKB.
DR   GO; GO:0042416; P:dopamine biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0051873; P:killing by host of symbiont cells; ISO:RGD.
DR   GO; GO:0006551; P:L-leucine metabolic process; ISO:RGD.
DR   GO; GO:0070945; P:neutrophil-mediated killing of gram-negative bacterium; ISS:UniProtKB.
DR   GO; GO:0006562; P:proline catabolic process; ISO:RGD.
DR   Gene3D; 3.30.9.10; D-Amino Acid Oxidase, subunit A, domain 2; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   InterPro; IPR006181; D-amino_acid_oxidase_CS.
DR   InterPro; IPR023209; DAO.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   PANTHER; PTHR11530; D-AMINO ACID OXIDASE; 1.
DR   PANTHER; PTHR11530:SF15; D-AMINO-ACID OXIDASE; 1.
DR   Pfam; PF01266; DAO; 1.
DR   PIRSF; PIRSF000189; D-aa_oxidase; 1.
DR   SUPFAM; SSF54373; FAD-linked reductases, C-terminal domain; 1.
DR   SUPFAM; SSF51971; Nucleotide-binding domain; 1.
DR   PROSITE; PS00677; DAO; 1.
PE   1: Evidence at protein level;
KW   Cell projection; Cytoplasm; FAD; Flavoprotein; Oxidoreductase; Peroxisome;
KW   Phosphoprotein; Reference proteome; S-nitrosylation; Secreted; Synapse.
FT   CHAIN           1..346
FT                   /note="D-amino-acid oxidase"
FT                   /id="PRO_0000162765"
FT   REGION          1..16
FT                   /note="Required for protein stability"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   REGION          215..227
FT                   /note="Active site lid that may open upon substrate/product
FT                   migration in and out of the active site and close to
FT                   increase the hydrophobicity of the active site, to make the
FT                   hydride transfer reaction more efficient"
FT                   /evidence="ECO:0000250|UniProtKB:P00371"
FT   MOTIF           344..346
FT                   /note="Microbody targeting signal"
FT   BINDING         8
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         9
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         10
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         11
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         36
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         37
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         42
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         43
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         44
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         48
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P00371"
FT   BINDING         49
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         50
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         52
FT                   /ligand="D-dopa"
FT                   /ligand_id="ChEBI:CHEBI:149689"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         162
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P00371"
FT   BINDING         163
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         181
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         223
FT                   /ligand="D-serine"
FT                   /ligand_id="ChEBI:CHEBI:35247"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         227
FT                   /ligand="D-proline"
FT                   /ligand_id="ChEBI:CHEBI:57726"
FT                   /evidence="ECO:0000250|UniProtKB:P00371"
FT   BINDING         227
FT                   /ligand="D-serine"
FT                   /ligand_id="ChEBI:CHEBI:35247"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         282
FT                   /ligand="D-dopa"
FT                   /ligand_id="ChEBI:CHEBI:149689"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         282
FT                   /ligand="D-proline"
FT                   /ligand_id="ChEBI:CHEBI:57726"
FT                   /evidence="ECO:0000250|UniProtKB:P00371"
FT   BINDING         282
FT                   /ligand="D-serine"
FT                   /ligand_id="ChEBI:CHEBI:35247"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         282
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         311
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         312
FT                   /ligand="D-dopa"
FT                   /ligand_id="ChEBI:CHEBI:149689"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         312
FT                   /ligand="D-proline"
FT                   /ligand_id="ChEBI:CHEBI:57726"
FT                   /evidence="ECO:0000250|UniProtKB:P00371"
FT   BINDING         312
FT                   /ligand="D-serine"
FT                   /ligand_id="ChEBI:CHEBI:35247"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         312
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         314
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         315
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
FT   BINDING         316
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P14920"
SQ   SEQUENCE   346 AA;  38820 MW;  2C4697960137A4FE CRC64;
     MRVAVIGAGV IGLSTALCIH ERYHPAQPLH MKIYADRFTP FTTSDVAAGL WQPYLSDPSN
     PQEAEWNQQT FDHLQSCLHS PNAEKMGLAL ISGYNLFRDE VPDPFWKSTV LGFRKLTPSE
     LDMFPDYSYG WFNTSLLLEG KSYLSWLTER LTERGVKFIH RKVASFEEVV RGGVDVIINC
     TGVWAGALQA DASLQPGRGQ IIQVEAPWIK HFILTHDPSL GIYNSPYIIP GSKTVTLGGV
     FQLGNWSELN SVHDHNTIWK SCCQLEPTLK NARIMGELTG FRPVRPQVRL ERERLRFGSS
     SAEVIHNYGH GGYGLTIHWG CAMEAANLFG KILEEKNLSR MPPSHL
//
